GR3024158T3 - Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes - Google Patents

Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes

Info

Publication number: GR3024158T3
Authority: GR; Greece
Prior art keywords: alpha; amino acid; group; peptidase; alkyl
Prior art date: 1988-10-07

Application number

GR970401803T

Other languages

English (en)

Inventor

Philippe Bey

Michael Angelastro

Shujaath Mehdi

Original Assignee

Merrell Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-07

Filing date

1997-07-18

Publication date

1997-10-31

1997-07-18 Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc

1997-10-31 Publication of GR3024158T3 publication Critical patent/GR3024158T3/el

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Detergent Compositions (AREA)
Enzymes And Modification Thereof (AREA)

GR970401803T 1988-10-07 1997-07-18 Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes GR3024158T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25476288A	1988-10-07	1988-10-07

Publications (1)

Publication Number	Publication Date
GR3024158T3 true GR3024158T3 (en)	1997-10-31

Family

ID=22965502

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR970401803T GR3024158T3 (en)	1988-10-07	1997-07-18	Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes

Country Status (18)

Country	Link
EP (2)	EP0363284B1 (el)
JP (2)	JP3203579B2 (el)
KR (2)	KR900006363A (el)
CN (2)	CN1041950A (el)
AT (2)	ATE153029T1 (el)
AU (1)	AU617875B2 (el)
CA (2)	CA2000342C (el)
DE (2)	DE68928662T2 (el)
DK (2)	DK494789A (el)
ES (2)	ES2118710T3 (el)
FI (2)	FI894747L (el)
GR (1)	GR3024158T3 (el)
HU (2)	HU895246D0 (el)
IL (2)	IL91896A0 (el)
NO (2)	NO894013L (el)
NZ (2)	NZ230893A (el)
PT (2)	PT91927B (el)
ZA (2)	ZA897515B (el)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5510531A (en) *	1989-04-10	1996-04-23	Suntory Limited	Proteinase inhibitor
EP0672648B1 (en) *	1989-04-15	1998-09-23	Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai	Threo (2R,3S)-3-amino-2-hydroxypentanoic acid and threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentanoic acid
IL97428A0 (en) *	1990-03-05	1992-06-21	Cephalon Inc	Chymotrypsin-like proteases and their inhibitors
GB9019558D0 (en) *	1990-09-07	1990-10-24	Szelke Michael	Enzyme inhibitors
US5444042A (en) *	1990-12-28	1995-08-22	Cortex Pharmaceuticals	Method of treatment of neurodegeneration with calpain inhibitors
EP0564561A4 (en) *	1990-12-28	1994-08-10	Georgia Tech Res Inst	Peptides ketoamides, ketoacids, and ketoesters
EP0587799B1 (en) *	1991-05-23	1999-07-07	Merrell Pharmaceuticals Inc.	Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
CA2071621C (en) *	1991-06-19	1996-08-06	Ahihiko Hosoda	Aldehyde derivatives
US6235929B1 (en)	1991-12-27	2001-05-22	Georgia Tech Research Corporation	Tripeptide α-ketoamides
US5610297A (en) *	1991-12-27	1997-03-11	Georgia Tech Research Corp.	Peptides ketoamides
US5514694A (en) *	1992-09-21	1996-05-07	Georgia Tech Research Corp	Peptidyl ketoamides
DE69414279T2 (de) *	1993-02-09	1999-04-08	Bayer Corp., Pittsburgh, Pa.	Sulfonamidaminomethylenderivate als Immunsuppressiva
US5672582A (en) *	1993-04-30	1997-09-30	Merck & Co., Inc.	Thrombin inhibitors
SE9301916D0 (sv) *	1993-06-03	1993-06-03	Ab Astra	New peptides derivatives
US5783563A (en) *	1993-06-03	1998-07-21	Astra Aktiebolag	Method for treatment or prophylaxis of venous thrombosis
US6984627B1 (en)	1993-06-03	2006-01-10	Astrazeneca Ab	Peptide derivatives
US5541290A (en) *	1993-06-24	1996-07-30	Harbeson; Scott L.	Optically pure calpain inhibitor compounds
EP0639585A1 (en) *	1993-08-20	1995-02-22	Banyu Pharmaceutical Co., Ltd.	Elastase inhibitor
US5977074A (en) *	1993-10-01	1999-11-02	Merrell Pharmaceuticals, Inc.	Inhibitors of β-amyloid protein production
IT1270882B (it) *	1993-10-05	1997-05-13	Isagro Srl	Oligopeptidi ad attivita' fungicida
US6060462A (en) *	1993-10-20	2000-05-09	Dupont Pharmaceuticals Company	Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
US5486623A (en)	1993-12-08	1996-01-23	Prototek, Inc.	Cysteine protease inhibitors containing heterocyclic leaving groups
US5693617A (en) *	1994-03-15	1997-12-02	Proscript, Inc.	Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6660268B1 (en)	1994-03-18	2003-12-09	The President And Fellows Of Harvard College	Proteasome regulation of NF-KB activity
DE4421052A1 (de)	1994-06-17	1995-12-21	Basf Ag	Neue Thrombininhibitoren, ihre Herstellung und Verwendung
DE4421884A1 (de)	1994-06-23	1996-01-04	Hoechst Ag	Verfahren zur Herstellung von Hydroxycarbonsäureaniliden
US5510369A (en) *	1994-07-22	1996-04-23	Merck & Co., Inc.	Pyrrolidine thrombin inhibitors
DE4427837A1 (de)	1994-08-05	1996-02-08	Hoechst Ag	Verfahren zur Herstellung von O-Acylglykolsäureaniliden
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
SE9404196D0 (sv) *	1994-12-02	1994-12-02	Astra Ab	New antithrombotic formulation
US5804560A (en) *	1995-01-06	1998-09-08	Sibia Neurosciences, Inc.	Peptide and peptide analog protease inhibitors
US5872101A (en) *	1995-01-06	1999-02-16	Sibia Neurosciences, Inc.	Methods of treating neurodegenerative disorders using protease inhibitors
US5691368A (en) *	1995-01-11	1997-11-25	Hoechst Marion Roussel, Inc.	Substituted oxazolidine calpain and/or cathepsin B inhibitors
FI119756B (fi)	1995-01-18	2009-03-13	Alteon Inc	Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa
BR9607598B1 (pt) *	1995-01-18	2009-05-05		composição farmacêutica, composição tópica, composição ocular e composto.
US5656261A (en)	1995-01-18	1997-08-12	The Picower Institute For Medical Research	Preventing and reversing advanced glycosylation endproducts
DE19504225A1 (de)	1995-02-09	1996-08-14	Hoechst Ag	Verfahren zur Herstellung von O-Acyloxycarbonsäureaniliden
CZ245797A3 (cs) *	1995-02-17	1998-06-17	Basf Aktiengesellschaft	Derivát amidinu dipeptidu jako inhibitor thrombinu
US5629324A (en) *	1995-04-10	1997-05-13	Merck & Co., Inc.	Thrombin inhibitors
US5919765A (en) *	1995-06-07	1999-07-06	Cor Therapeutics, Inc.	Inhibitors of factor XA
US5721214A (en) *	1995-06-07	1998-02-24	Cor Therapeutics, Inc.	Inhibitors of factor Xa
US6069130A (en)	1995-06-07	2000-05-30	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) *	1995-06-07	2000-04-04	Cor Therapeutics, Inc.	Inhibitors of factor XA
US6211154B1 (en)	1995-06-07	2001-04-03	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
US6022861A (en) *	1995-06-07	2000-02-08	Cor Therapeutics, Inc.	Ketoheterocyclic inhibitors of factor Xa
SA96170106A (ar)	1995-07-06	2005-12-03	أسترا أكتيبولاج	مشتقات حامض أميني جديدة
US5827877A (en)	1995-09-14	1998-10-27	Cephalon, Inc.	Ketomethylene group-containing cysteine and serine protease inhibitors
US5723580A (en) *	1995-09-14	1998-03-03	Cephalon, Inc.	Ketomethylene group-containing aldehyde cysteine and serine protease inhibitors
US5763576A (en) *	1995-10-06	1998-06-09	Georgia Tech Research Corp.	Tetrapeptide α-ketoamides
ATE228760T1 (de) *	1995-10-24	2002-12-15	Merck & Co Inc	Thrombininhibitoren
KR100490807B1 (ko) *	1995-11-28	2005-10-14	세파론, 인코포레이티드	시스테인및세린프로테아제의d-아미노산함유억제제
TW541316B (en)	1995-12-21	2003-07-11	Astrazeneca Ab	Prodrugs of thrombin inhibitors
US6245743B1 (en)	1996-06-05	2001-06-12	Cor Therapeutics, Inc.	Inhibitors of factor Xa
SE9602263D0 (sv)	1996-06-07	1996-06-07	Astra Ab	New amino acid derivatives
SE9602646D0 (sv)	1996-07-04	1996-07-04	Astra Ab	Pharmaceutically-useful compounds
US5792761A (en) *	1996-08-12	1998-08-11	Merck & Co., Inc.	Thrombin inhibitors
KR20000068354A (ko) *	1996-09-06	2000-11-25	다께다 가즈히꼬	신규 아세트아미드 유도체 및 프로테아제 저해제
EP1136498A1 (en) *	1996-10-18	2001-09-26	Vertex Pharmaceuticals Incorporated	Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease
KR100509388B1 (ko) *	1996-10-18	2005-08-23	버텍스 파마슈티칼스 인코포레이티드	세린 프로테아제, 특히 간염 ｃ 바이러스 ｎｓ３ 프로테아제의 저해제
US5798377A (en) *	1996-10-21	1998-08-25	Merck & Co., Inc.	Thrombin inhibitors
DE19648793A1 (de)	1996-11-26	1998-05-28	Basf Ag	Neue Benzamide und deren Anwendung
AU6134498A (en) *	1997-03-07	1998-09-22	Hoechst Marion Roussel, Inc.	Method of treating trauma associated with brain, spinal cord or peripheral nerveinjury using carbobenzyloxy n-protected di- and tripeptide phenylalaninals
AR013084A1 (es)	1997-06-19	2000-12-13	Astrazeneca Ab	Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
WO1999026926A1 (en)	1997-11-26	1999-06-03	3-Dimensional Pharmaceuticals, Inc.	Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
US6011047A (en) *	1997-11-26	2000-01-04	Corvas International Inc.	Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors
US6204384B1 (en)	1997-11-26	2001-03-20	Corvas International, Inc.	Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (II)
SE9704543D0 (sv)	1997-12-05	1997-12-05	Astra Ab	New compounds
US6740647B1 (en)	1998-01-26	2004-05-25	Abbott Gmbh & Co., Kg	Thrombin inhibitors
ES2288807T1 (es)	1998-02-02	2008-02-01	Trustees Of Tufts College	Uso de inhibidores de dipeptidasa para regular el metabolismo de la glucosa.
CN1769274A (zh)	1998-06-11	2006-05-10	奥瑟－麦内尔制药公司	吡嗪酮蛋白酶抑制剂
SE9804313D0 (sv)	1998-12-14	1998-12-14	Astra Ab	New compounds
EE200100371A (et)	1999-01-13	2002-02-15	Astrazeneca Ab	Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
AR023510A1 (es)	1999-04-21	2002-09-04	Astrazeneca Ab	Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
JP2003501352A (ja)	1999-05-27	2003-01-14	３−ディメンショナルファーマシューティカルズ，インコーポレイテッド	プロテアーゼ阻害剤としてのオキサザ複素環
DE60005351D1 (de)	1999-07-09	2003-10-23	Dimensional Pharm Inc	Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
US6630510B1 (en) *	1999-10-28	2003-10-07	Merck & Co., Inc.	Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
WO2001055118A1 (fr) *	2000-01-26	2001-08-02	Ono Pharmaceutical Co., Ltd.	Derives heterocycliques condenses au benzene et medicaments contenant ceux-ci comme ingredients actifs
SE0001803D0 (sv)	2000-05-16	2000-05-16	Astrazeneca Ab	New compounds i
AU2001265094A1 (en)	2000-06-01	2001-12-11	Merck And Co., Inc.	Pyrazinone thrombin inhibitors
JP2004504305A (ja)	2000-07-17	2004-02-12	３−ディメンショナル　ファーマシューティカルズ，　インコーポレイテッド	プロテアーゼインヒビターとしての環状オキシグアニジンピラジノン
US7244721B2 (en)	2000-07-21	2007-07-17	Schering Corporation	Peptides as NS3-serine protease inhibitors of hepatitis C virus
BR0112666A (pt)	2000-07-21	2003-06-10	Schering Corp	Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
JP4298289B2 (ja)	2000-07-21	2009-07-15	シェーリングコーポレイション	Ｃ型肝炎ウイルスのｎｓ３−セリンプロテアーゼ阻害剤としての新規ペプチド
WO2002012207A1 (en)	2000-08-04	2002-02-14	3-Dimensional Pharmaceuticals, Inc.	Cyclic oxyguanidine protease inhibitors
US6433186B1 (en)	2000-08-16	2002-08-13	Astrazeneca Ab	Amidino derivatives and their use as thormbin inhibitors
AR035216A1 (es)	2000-12-01	2004-05-05	Astrazeneca Ab	Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en)	2000-12-01	2006-10-31	Astrazeneca Ab	Mandelic acid derivatives and their use as thrombin inhibitors
CA2431588A1 (en)	2000-12-18	2002-06-27	Merck & Co., Inc.	Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en)	2000-12-18	2003-03-04	Merck & Co., Inc.	Thrombin inhibitors
US6610701B2 (en)	2001-02-09	2003-08-26	Merck & Co., Inc.	Thrombin inhibitors
CA2436176A1 (en)	2001-02-09	2002-08-22	Merck & Co., Inc.	Thrombin inhibitors
AR034517A1 (es)	2001-06-21	2004-02-25	Astrazeneca Ab	Formulacion farmaceutica
US6777431B2 (en)	2001-07-13	2004-08-17	Corvas International, Inc.	Non-convalent thrombin inhibitors
JP2005511636A (ja)	2001-11-26	2005-04-28	トラスティーズオブタフツカレッジ	自己免疫疾患の治療方法及びそれに関する試薬
US7084134B2 (en)	2002-05-02	2006-08-01	Merk & Co., Inc.	Thrombin inhibitors
SE0201661D0 (sv)	2002-05-31	2002-05-31	Astrazeneca Ab	New salts
SE0201659D0 (sv)	2002-05-31	2002-05-31	Astrazeneca Ab	Modified release pharmaceutical formulation
GB0217136D0 (en)	2002-07-24	2002-09-04	Renovo Ltd	Wound healing & treatment of fibrosis
WO2004043374A2 (en)	2002-11-06	2004-05-27	Dana-Farber Cancer Institute, Inc.	Methods and compositions for treating cancer using proteasome inhibitors
US20050014747A1 (en)	2003-04-18	2005-01-20	Emily Reinhard	Dihydrothiazine prodrugs of thiazolium agents
US7781424B2 (en)	2003-05-27	2010-08-24	Astrazeneca Ab	Modified release pharmaceutical formulation
TW201127828A (en)	2003-09-05	2011-08-16	Vertex Pharma	Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
US7795205B2 (en)	2004-04-12	2010-09-14	Canyon Pharmaceuticals, Inc.	Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
JP2009510131A (ja)	2005-10-07	2009-03-12	バイオファルミカリミテッド	Ｓｕｍｏ化制御剤及びその用途
JP3975226B2 (ja)	2006-01-11	2007-09-12	生化学工業株式会社	シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
JP4047365B2 (ja)	2006-01-11	2008-02-13	生化学工業株式会社	シクロアルカンカルボキサミド誘導体及びその製造方法
WO2007080884A1 (ja)	2006-01-11	2007-07-19	Seikagaku Corporation	シクロアルキルカルボニルアミノ酸エステル誘導体及びその製造方法
US20090258827A1 (en)	2006-04-07	2009-10-15	Biopharmica Ltd.	Transcription Factor Modulator
TW200827336A (en)	2006-12-06	2008-07-01	Astrazeneca Ab	New crystalline forms
EP2922535B1 (en)	2012-11-20	2021-11-10	Merck Sharp & Dohme Corp.	Thrombin inhibitors
WO2019026208A1 (ja) *	2017-08-02	2019-02-07	株式会社広島メタル＆マシナリー	分散機と、スラリー中粒子の分散方法及びエマルジョン製造方法
RU2020134124A (ru)	2018-03-20	2022-04-20	АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи	СПОСОБЫ ЛЕЧЕНИЯ НАРУШЕНИЙ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ ПУТЕМ ВВЕДЕНИЯ СОДЕРЖАЩИХ ИНГИБИТОР mTOR И АЛЬБУМИН НАНОЧАСТИЦ

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4920118A (el) *	1972-06-23	1974-02-22
JPS594415B2 (ja) *	1974-02-18	1984-01-30	帝人株式会社	Ｄ，ｌ−２− アミノ −１− ブタノ−ルノコウガクブンカツホウ
JPS50142505A (el) *	1974-05-08	1975-11-17
HU177098B (en) *	1979-01-04	1981-07-28	Gyogyszerkutato Intezet	Process for producing new peptidyl-n-carboxy-l-arginin-a
JPS55138389A (en) *	1979-04-14	1980-10-29	Denki Kagaku Kogyo Kk	Preparation of amino alcohols
FR2537131B1 (fr) *	1980-04-17	1986-05-09	Roques Bernard	Nouveaux derives d'acides amines et leur application therapeutique
JPS5754157A (en) *	1980-09-19	1982-03-31	Nippon Kayaku Co Ltd	L-argininal derivative and its preparation
JPS58198296A (ja) *	1982-05-12	1983-11-18	Chisso Corp	ｄ−２−アミノブタノ−ルの製造法
GB2124233B (en) *	1982-07-19	1985-09-18	Nat Res Dev	Synthetic peptides and their preparation
EP0124317B1 (en) *	1983-04-27	1990-04-11	Ici Americas Inc.	Proline derivatives
GB8312339D0 (en) *	1983-05-05	1983-06-08	Austen B M	Peptides
FR2546164B1 (fr) *	1983-05-16	1987-07-17	Centre Nat Rech Scient	Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
JPS59227851A (ja) *	1983-06-09	1984-12-21	Sankyo Co Ltd	レニン阻害作用を有するペプチド類
CA1267499A (en) *	1983-07-12	1990-04-03	Cedric H. Hassall	Peptide amides and aldehydes
DK34086A (da) *	1985-01-23	1986-07-24	Abbott Lab	Peptidylaminodioler
AU600226B2 (en) *	1985-02-04	1990-08-09	Merrell Pharmaceuticals Inc.	Novel peptidase inhibitors
US4851387A (en) *	1986-10-14	1989-07-25	Banyu Pharmaceutical Co., Ltd.	5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
MY103189A (en) *	1986-10-31	1993-05-29	Pfizer	Nor-statine and nor-cyclostatine polypeptides
FI89058C (fi) *	1987-02-27	1993-08-10	Yamanouchi Pharma Co Ltd	Foerfarande foer framstaellning av som remin-inhibitorer anvaenda 2-(l-alanyl-l-histidylamino)-butanol-derivat
US4820691A (en) *	1987-06-24	1989-04-11	E. R. Squibb & Sons, Inc.	Amino acid 1,2-diketo derivatives as renin inhibitors
US4913296A (en) *	1988-03-30	1990-04-03	Applied Power Inc.	Storing and dispensing system
DE3827415A1 (de) *	1988-08-12	1990-02-15	Behringwerke Ag	Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung

1989
- 1989-10-03 ZA ZA897515A patent/ZA897515B/xx unknown
- 1989-10-03 ZA ZA897514A patent/ZA897514B/xx unknown
- 1989-10-04 AU AU42491/89A patent/AU617875B2/en not_active Ceased
- 1989-10-04 NZ NZ230893A patent/NZ230893A/en unknown
- 1989-10-05 NZ NZ230916A patent/NZ230916A/en unknown
- 1989-10-05 IL IL91896A patent/IL91896A0/xx unknown
- 1989-10-05 IL IL91895A patent/IL91895A0/xx unknown
- 1989-10-06 FI FI894747A patent/FI894747L/fi not_active IP Right Cessation
- 1989-10-06 ES ES89402763T patent/ES2118710T3/es not_active Expired - Lifetime
- 1989-10-06 AT AT89402762T patent/ATE153029T1/de not_active IP Right Cessation
- 1989-10-06 DK DK494789A patent/DK494789A/da not_active Application Discontinuation
- 1989-10-06 HU HU895246A patent/HU895246D0/hu unknown
- 1989-10-06 HU HU895247A patent/HUT54105A/hu unknown
- 1989-10-06 NO NO89894013A patent/NO894013L/no unknown
- 1989-10-06 NO NO89894014A patent/NO894014L/no unknown
- 1989-10-06 KR KR1019890014375A patent/KR900006363A/ko not_active Withdrawn
- 1989-10-06 DE DE68928662T patent/DE68928662T2/de not_active Expired - Fee Related
- 1989-10-06 AT AT89402763T patent/ATE165835T1/de not_active IP Right Cessation
- 1989-10-06 JP JP26036089A patent/JP3203579B2/ja not_active Expired - Fee Related
- 1989-10-06 DE DE68928042T patent/DE68928042T2/de not_active Expired - Fee Related
- 1989-10-06 PT PT91927A patent/PT91927B/pt not_active IP Right Cessation
- 1989-10-06 JP JP1260361A patent/JPH02134398A/ja active Pending
- 1989-10-06 PT PT91926A patent/PT91926B/pt not_active IP Right Cessation
- 1989-10-06 DK DK494689A patent/DK494689A/da not_active Application Discontinuation
- 1989-10-06 EP EP89402762A patent/EP0363284B1/en not_active Expired - Lifetime
- 1989-10-06 FI FI894748A patent/FI894748L/fi not_active IP Right Cessation
- 1989-10-06 ES ES89402762T patent/ES2103709T3/es not_active Expired - Lifetime
- 1989-10-06 KR KR1019890014374A patent/KR900006362A/ko not_active Withdrawn
- 1989-10-06 EP EP89402763A patent/EP0364344B1/en not_active Expired - Lifetime
- 1989-10-07 CN CN89107699A patent/CN1041950A/zh active Pending
- 1989-10-07 CN CN89107700A patent/CN1041951A/zh active Pending
- 1989-10-10 CA CA002000342A patent/CA2000342C/en not_active Expired - Fee Related
- 1989-10-10 CA CA002000340A patent/CA2000340A1/en not_active Abandoned
1997
- 1997-07-18 GR GR970401803T patent/GR3024158T3/el unknown

Also Published As

Publication number	Publication date
FI894747A0 (fi)	1989-10-06
ES2118710T3 (es)	1998-10-01
IL91895A0 (en)	1990-06-10
DE68928042T2 (de)	1997-08-28
AU4249189A (en)	1990-06-28
FI894747L (fi)	1990-04-08
CA2000342A1 (en)	1990-04-07
DE68928662T2 (de)	1998-11-26
EP0364344A3 (en)	1991-09-11
KR900006362A (ko)	1990-05-08
PT91926A (pt)	1990-04-30
NO894013L (no)	1990-04-09
NO894013D0 (no)	1989-10-06
EP0363284B1 (en)	1997-05-14
DK494789A (da)	1990-04-08
JP3203579B2 (ja)	2001-08-27
EP0364344A2 (en)	1990-04-18
HUT54105A (en)	1991-01-28
ES2103709T3 (es)	1997-10-01
EP0363284A2 (en)	1990-04-11
EP0363284A3 (en)	1992-07-01
PT91927A (pt)	1990-04-30
NZ230916A (en)	1992-02-25
ZA897514B (en)	1990-06-27
AU4262589A (en)	1990-04-12
JPH02134398A (ja)	1990-05-23
JPH02256654A (ja)	1990-10-17
NO894014L (no)	1990-04-09
AU617875B2 (en)	1991-12-05
ATE165835T1 (de)	1998-05-15
EP0364344B1 (en)	1998-05-06
ZA897515B (en)	1990-06-27
FI894748L (fi)	1990-04-08
CA2000340A1 (en)	1990-04-07
NO894014D0 (no)	1989-10-06
KR900006363A (ko)	1990-05-08
CN1041951A (zh)	1990-05-09
PT91927B (pt)	1995-07-03
DK494789D0 (da)	1989-10-06
CN1041950A (zh)	1990-05-09
HU895247D0 (el)	1990-01-28
HU895246D0 (en)	1990-01-28
DK494689A (da)	1990-04-08
AU626918B2 (en)	1992-08-13
DE68928042D1 (de)	1997-06-19
FI894748A0 (fi)	1989-10-06
NZ230893A (en)	1992-01-29
CA2000342C (en)	2000-10-03
ATE153029T1 (de)	1997-05-15
IL91896A0 (en)	1990-06-10
PT91926B (pt)	1995-07-03
DK494689D0 (da)	1989-10-06
DE68928662D1 (de)	1998-06-10

Publication	Publication Date	Title
GR3024158T3 (en)	1997-10-31	Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes
EP0393457B1 (en)	1994-07-06	Proteinase inhibitor
CO4950618A1 (es)	2000-09-01	Inhibidores de proteasas
HK1010378A1 (en)	1999-06-17	Peptide derivatives of the boronic acid having protease inhibiting activity process for their production and pharmaceutical compositions comprising them
US5661167A (en)	1997-08-26	Prolyl endopeptidase inhibitors
NO891484L (no)	1989-10-13	Fremgangsmaate for fremstilling av cyklometylen-1,2-bikarboksylsyreamider med terapeutisk aktivitet og farmasoeytiskesammensetninger derav.
DE69810651D1 (de)	2003-02-13	Azetidinonderivate zur behandlung von hcmv entzündungen
AU1270402A (en)	2002-05-15	Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
NO921852L (no)	1992-05-11	N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning
CA2251060A1 (en)	1997-10-16	Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
WO2000078793A3 (en)	2001-03-22	Antimicrobial agents
ATE46347T1 (de)	1989-09-15	Immunostimulierende peptide.
ES2075798A1 (es)	1995-10-01	Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina.